CN101843868A - Chinese medicament for treating diabetic acro-necrosis - Google Patents
Chinese medicament for treating diabetic acro-necrosis Download PDFInfo
- Publication number
- CN101843868A CN101843868A CN200910237121A CN200910237121A CN101843868A CN 101843868 A CN101843868 A CN 101843868A CN 200910237121 A CN200910237121 A CN 200910237121A CN 200910237121 A CN200910237121 A CN 200910237121A CN 101843868 A CN101843868 A CN 101843868A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese
- chinese medicine
- radix
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating diabetic acro-necrosis, and belongs to the field of Chinese medicaments for treating surgery diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: officinal magnolia bark, radix pseudo-ginseng, root of rehmannia, largehead atractylodes rhizome, lucid ganoderma, folium llicis latifoliae, Chinese angelica, coix seed and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, drying dampness and disinhibiting water, and activating blood, dissolving stasis and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment surgery diseases.
Background technology
The Western medicine and the Chinese medicine that are used for the treatment of acromegaly necrosis diabetes at present exist some significantly not enough: the one, and DeGrain, the 2nd, it is slower to take effect, a large amount of patients feel simply helpless in the face of acromegaly necrosis diabetes, suffer from the limb obstinate, constantly worsen, the amputation of being compelled to do is at last handled.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of acromegaly necrosis diabetes, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of acromegaly necrosis diabetes adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Cortex Magnoliae Officinalis 4-30 part Radix Notoginseng 3-20 part Radix Rehmanniae 4-30 part
Rhizoma Atractylodis Macrocephalae 4-30 part Ganoderma 2-12 part Folium Ilicis 4-30 part
Radix Angelicae Sinensis 4-30 part Semen Coicis 4-30 part
The Chinese medicine of this treatment acromegaly necrosis diabetes is made by following method:
(1) by above-mentioned weight ratio, Cortex Magnoliae Officinalis, the Radix Rehmanniae, the Rhizoma Atractylodis Macrocephalae, Folium Ilicis, Radix Angelicae Sinensis, Semen Coicis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, tonification the five internal organs, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng blood-supplementing blood-nourishing, promoting blood circulation, removing blood stasis and relieving pain; Be aided with Cortex Magnoliae Officinalis, Semen Coicis invigorating the spleen for eliminating dampness; Rhizoma Atractylodis Macrocephalae dampness diuretic; The Folium Ilicis heat-clearing and toxic substances removing is damp and hot with Qinghua.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and the dampness diuretic, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Cortex Magnoliae Officinalis 80 gram Radix Notoginseng 60 gram Radix Rehmanniae 80 grams
The Rhizoma Atractylodis Macrocephalae 80 kairine sesames 40 gram Folium Ilicis 80 grams
Radix Angelicae Sinensis 80 gram Semen Coiciss 80 grams
Weight in accordance with regulations, with conventional water extraction process Cortex Magnoliae Officinalis, the Radix Rehmanniae, the Rhizoma Atractylodis Macrocephalae, Folium Ilicis, Radix Angelicae Sinensis, Semen Coicis are extracted, make extractum fine powder 144 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 871 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Cortex Magnoliae Officinalis 160 gram Radix Notoginseng 90 gram Radix Rehmanniae 160 grams
The Rhizoma Atractylodis Macrocephalae 160 kairine sesames 60 gram Folium Ilicis 160 grams
Radix Angelicae Sinensis 160 gram Semen Coiciss 160 grams
By above-mentioned same method, make 1564 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Cortex Magnoliae Officinalis 300 gram Radix Notoginseng 180 gram Radix Rehmanniae 300 grams
The Rhizoma Atractylodis Macrocephalae 300 kairine sesames 120 gram Folium Ilicis 250 grams
Radix Angelicae Sinensis 300 gram Semen Coiciss 300 grams
By above-mentioned same method, make 3017 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts in 4 parts of Radix Rehmanniae of 7 portions of Radix Notoginseng of Cortex Magnoliae Officinalis
7 parts of 3 parts of Folium Ilicis of 7 portions of Ganodermas of the Rhizoma Atractylodis Macrocephalae
7 parts of 7 parts of Semen Coiciss of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts in 10 parts of Radix Rehmanniae of 15 portions of Radix Notoginseng of Cortex Magnoliae Officinalis
15 parts of 6 parts of Folium Ilicis of 15 portions of Ganodermas of the Rhizoma Atractylodis Macrocephalae
15 parts of 15 parts of Semen Coiciss of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science acromegaly necrosis diabetes, through 7 routine clinical observations.Selecting the tcm diagnosis acromegaly necrosis diabetes is standard: the diabetics emaciated physique, and limb is soft weak; Suffer from limb and send out cold, poor blood circulation; Amyotrophy; The lower limb weak and faint pulse, intermittent claudication; Legs and feet skin rubefaction, blackout, blue, tissue necrosis; Numb limbs and tense tendons is suffered from the limb acrodynia; Suffer from limb acra ulcer, fester, bleed and suppurate, disunion for a long time.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 3 examples do not have other serious disease, and the age is 47 years old-78 years old, 65 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Limbs are warm, send out cool the disappearance; Skin color is progressively bleached (normal skin color) by black purple, and blood circulation obviously improves; Trouble acroanesthesia, acrodynia obviously alleviate; Acra fester alleviation, the healing.
2, effective: body constitution strengthens, and on one's body energetically, limbs are warm, and blood circulation improves; Numb limbs and tense tendons, pain are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, except that hypoglycemic medicine, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. a Chinese medicine for the treatment of acromegaly necrosis diabetes adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Cortex Magnoliae Officinalis 4---30 parts of 30 portions of Radix Notoginseng 3---20 parts of Radix Rehmanniae 4---
The Rhizoma Atractylodis Macrocephalae 4---30 parts of 30 portions of Ganodermas 2---12 parts of Folium Ilicis 4---
30 parts of Radix Angelicae Sinensis 4---30 parts of Semen Coiciss 4---
The Chinese medicine of this treatment acromegaly necrosis diabetes is made by following method:
(1) by above-mentioned weight ratio, Cortex Magnoliae Officinalis, the Radix Rehmanniae, the Rhizoma Atractylodis Macrocephalae, Folium Ilicis, Radix Angelicae Sinensis, Semen Coicis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910237121A CN101843868A (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating diabetic acro-necrosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910237121A CN101843868A (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating diabetic acro-necrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101843868A true CN101843868A (en) | 2010-09-29 |
Family
ID=42768807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910237121A Pending CN101843868A (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating diabetic acro-necrosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101843868A (en) |
-
2009
- 2009-11-04 CN CN200910237121A patent/CN101843868A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101390993B (en) | Traditional Chinese medicine for treating diabetic foot | |
CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
CN102380063A (en) | Chinese medicament for treating diabetic foot | |
CN102389547A (en) | Traditional Chinese medicine for treating diabetic foot | |
CN101954024A (en) | Traditional Chinese medicament for treating diabetic foot | |
CN101850019A (en) | Chinese medicament for treating diabetic acromelic gangrene | |
CN102018765A (en) | Traditional Chinese medicine for treating diabetic acromelic gangrene | |
CN101843738A (en) | Chinese medicament for treating diabetic feet | |
CN101843878B (en) | Chinese medicament for treating diabetic cardiopathy | |
CN102380065A (en) | Traditional Chinese medicine for treating diabetic feet | |
CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
CN101843870B (en) | Chinese medicament for treating diabetic acro-necrosis | |
CN101554445B (en) | Traditional Chinese medicine for treating diabetic hyperlipemia | |
CN101843679B (en) | Chinese medicament for treating cervical spondylosis | |
CN101843871B (en) | Chinese medicament for treating diabetic acro-necrosis | |
CN101843864A (en) | Chinese medicament for treating diabetic acro-necrosis | |
CN101843866A (en) | Chinese medicament for treating diabetic feet | |
CN101843868A (en) | Chinese medicament for treating diabetic acro-necrosis | |
CN101843802A (en) | Chinese medicament for treating diabetic acro-necrosis | |
CN101843737A (en) | Chinese medicament for treating diabetic feet | |
CN101554418B (en) | Traditional Chinese medicine for treating diabetic peripheral neuritis | |
CN102380067A (en) | Traditional Chinese medicine for treating diabetic foot | |
CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100929 |